JM Canty International and NIBRT Team Up for Optical System Research Collaboration
The companies plan to collaborate for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.
JM Canty International, a fused sight glass company headquartered in Buffalo, NY, and the National Institute for Bioprocessing Research and Training (NIBRT) announced a research collaboration for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.
The Enterprise Ireland-funded collaboration will use a Pharmaflow imaging system that will monitor cell viability in real time with high resolution, without the need for a cell stain, according to a Sept. 27, 2019 press release. Cantyvision software will capture information on cell morphology, including roundness and granularity, while remaining non-destructive to the sample because of the constant analysis of bench-top bioreactors.
The research will be led by Michael Butler, a professor at NIBRT, and will include two members of the NIBRT Cell Technology team and a newly appointed post-doctoral researcher.
“This collaboration will enable us to use the high-resolution optical system developed by Canty in advanced monitoring and control protocols for bioprocesses to produce therapeutic proteins and other cellular therapies,” said Butler in the press release.
Source: NIBRT
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
